Rituximab Treatment for Antibody-Mediated Rejection (AMR ...BACKGROUND Antibody Mediated Rejection (AMR)1,2 •Rejectionthatoccursduetoantibodiesagainstdonor-specificantigen(DSA) –Antibodiesactivatecomplementsystem
Fri, 01 May 2015 22:05:00 GMT
Rituximab and other antibodies in the treatment of lymphoma4/8 Rituximab and other antibodies for lymphoma LYM0039/Ritux&antibodies/2014v2 Chronic lymphocytic leukaemia Rituximab can be used as part of the initial treatment ...
Sun, 03 May 2015 11:47:00 GMT
NHS England Clinical Commissioning Policy: Rituximab for ...1 Interim Clinical Commissioning Policy Statement: Rituximab for the treatment of Systemic Lupus Erythematosus in adults September 2013 Reference: NHS ENGLAND
Tue, 28 Apr 2015 17:37:00 GMT
Bendamustine in Combination With Rituximab for Previously ...Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German
Thu, 30 Apr 2015 23:04:00 GMT
Next generation monoclonal antibodies and their mechanisms ...iii 3 ABSTRACT Next generation monoclonal antibodies (mAbs) are unique in that they are specifically designed to enhance their mechanisms of action, primarily
Wed, 29 Apr 2015 08:32:00 GMT
rituximab, 100mg in 10mL, 500mg in 50mL, concentrate for ...2 Indication Rituximab maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. Dosing Information
Fri, 01 May 2015 13:09:00 GMT
Dose-Adjusted EPOCH-Rituximab Therapy in Primary ...EPOCH-Rituximab in Mediastinal B-Cell Lymphoma n engl j med 368;15 nejm.org april 11, 2013 1409 P rimary mediastinal B-cell lympho-ma is a distinct ...
Thu, 30 Apr 2015 12:34:00 GMT
Guidelines - Oxford JournalsGuidelines doi:10.1093/rheumatology/ker106b BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis Marwan Bukhari1, Rikki Abernethy2, Chris Deighton3 ...
Thu, 30 Apr 2015 11:58:00 GMT
Rituximab versus Cyclophosphamide in ANCA associated renal ...n engl j med 363;3 nejm.org july 15, 2010 211 The new england journal of medicine established in 1812 july 15, 2010 vol. 363 no. 3 Rituximab versus ...
Sat, 02 May 2015 09:40:00 GMT
Leukemia - M.D. Anderson Cancer CenterCLL Treatment Priorities 1. untreated • Fludarabine + Cytoxan + Rituximab (FCR) (2008-0431) • Ofatumumab (2010-0241/2011-0520) • Lenalidomide + Rituximab
Fri, 01 May 2015 11:50:00 GMT